Saquinavir

This page contains recent news articles, when available, and an overview of Saquinavir but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Saquinavir
(when available)

Pharmacology and use:
Saquinavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Saquinavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs. HIV-1 with advanced immunodeficiency together with antiretroviral nucleoside analogues

Mechanism Of Action:
Saquinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles.

News Articles on Saquinavir

Conflictul alimente – medicamente  -  ‎Jan 4, 2010‎
...antiviralele (Saquinavir mesylate), antiaritmicele cardiace (Cardarone), antialgicele (cpodeina), antibioticele (aritromicina, claritromicina). ... Jurnalul Naţional

Lower Norvir Boosting Dose Possible  -  ‎Oct 29, 2009‎
Three protease inhibitors (PIs)—Invirase (saquinavir), Prezista (darunavir) and Lexiva (fosamprenavir)—might require a lower dose of Norvir (ritonavir) to ... AIDSmeds.com HIV/AIDS Treatment News

US: “Health benefits and risks of grapefruit and grapefruit juiceâ€?  -  ‎Nov 12, 2009‎
...cyclosporine, ethinyl, estradiol, felodipine, lovastatin, nifedipine, nimodipine, saquinavir, simvastatin, tacrolimus, testosterone, triazolam. ... FreshPlaza

Market Watch  -  ‎Nov 5, 2009‎
...nefazodone, nelfinavir, ritonavir, saquinavir, or telithromycin). The most common adverse effects in clinical trials were respiratory tract infection, ... The Hospitalist Online

New drug for type 2 diabetes  -  ‎Oct 29, 2009‎
...nelfinavir, ritonavir, saquinavir, telithromycin). Concomitant sulfonylurea: may need lower dose of sulfonylurea to reduce risk of hypoglycemia. ... Clinical Advisor

Alerta VIH  -  ‎Nov 1, 2009‎
Quien nos escribe denuncia que ha tenido que interrumpir su tratamiento desde hace 15 días, pues en Valera no disponen de saquinavir ni de lamivudina. ... El Universal (Venezuela)

Pharmacokinetics and Safety of Saquinavir/Ritonavir and Omeprazole in...  -  Feb 5, 2007
We investigated the pharmacokinetics and safety of saquinavir/ritonavir when administered with omeprazole simultaneously and 2 h apart to human ... Nature.com

Variation in oral clearance of saquinavir is predicted by CYP3A5*1 …  -  Jan 28, 2005
Correspondence: Paul B. Watkins, MD, General Clinical Research Center, Campus Box 7600, Room 3005 APCF, University of North Carolina, School of Medicine, ... Nature.com

Boosted Invirase (saquinavir) 500 Has Similar Efficacy And An Overall...  -  Jul 25, 2007
Encouraging 24 week, full cohort head to head results of an international trial demonstrate that HIV-infected patients initiating treatment with the boosted ... Medical News Today - Medical News Today (press release)

Learn about Saquinavir from Consumer Reports Health.  -  Jan 10, 2005
Saquinavir is used in combination with other medications to treat human immunodeficiency virus (HIV) infection in patients with or without acquired ... consumerreports.org

Roche agrees HIV drug technology transfers with four countries in...  -  Jan 9, 2008
The generic drugs, based upon Saquinavir, Roche's second line HIV medicine, will be manufactured by Regal Pharmaceuticals in Kenya, CAPS Holdings in ... Forbes

Saquinavir (Systemic).(Drug overview)  -  May 1, 2006
Saquinavir ( sa-KWIN-a-veer) is used, usually in combination with other HIV medicines including ritonavir (eg, Norvir), in the treatment of the infection ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Roche to transfer technology for Saquinavir to three generic drug …  -  Sep 26, 2006
Switzerland-based pharmaceutical company Roche on Friday said it will provide three generic drug companies in sub-Saharan Africa assistance in producing the ... News-Medical.net

Reyataz Oral : Uses, Side Effects, Interactions, Pictures, Warnings &...  -  Sep 30, 2008
Invirase (saquinavir mesylate) US prescribing information. ... Oral contraception does not alter single dose saquinavir pharmacokinetics in women. ... WebMD

Saquinavir (Systemic).  -  Jul 28, 2005
Saquinavir ( sa-KWIN-a-veer) is used, usually in combination with other HIV medicines including ritonavir (eg, Norvir), in the treatment of the infection ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Drug testing | The invisible man | Economist.com  -  Jan 31, 2008
The drug in question is saquinavir, one of a class known as protease inhibitors, which revolutionised the treatment of AIDS when they were introduced in ... economist.com

Ritonavir/Saquinavir plus Rifampicin in HIV Patients with Tuberculosis...  -  Oct 30, 2006
Objective: To assess the drug concentrations, efficacy and safety of concomitant use of rifampicin and regimens containing ritonavir/saquinavir (400mg/400mg ... Medscape

Pharmacokinetics of New Saquinavir Tablet Adequate in Pregnant …  -  Mar 2, 2007
By Ed Susman. LOS ANGELES, CA -- March 2, 2007 -- The new formulation of saquinavir in a 500-mg tablet appears to have adequate pharmacokinetics in a trial ... DG News

Once-daily boosted saquinavir has low blood levels when used with key...  -  Nov 12, 2005
Over a third of patients who take once-daily ritonavir-boosted saquinavir with the anti-tuberculosis drug, rifampicin, have blood levels of saquinavir which ... Aidsmap

Zimbabwe: Caps Seals Deal With Swiss Firm  -  Jan 17, 2008
Saquinavir is a protease inhibitor (PI) which, when combined with some of CAPS' ARVs, will form a better and affordable second line treatment regimen for ... AllAfrica.com

… on Availability of Invirase, Now Preferred Formulation of Saquinavi...  -  Feb 6, 2006
..."The Fortovase formulation of saquinavir no longer meets the demands of convenience ... When using saquinavir as the sole protease inhibitor in an antiviral ... DG News

Africa: Healthcare Group Furthers Manufacture of Generic HIV Medicine  -  May 30, 2007
...technical expertise and guidance to manufacture generic HIV medicine, based upon the processes to produce saquinavir, Roche's 2nd line1 HIV medicine. ... AllAfrica.com

IAS: Virological failure rare in patients taking saquinavir /...  -  Jul 30, 2005
The study's investigators argue that this supports the use of saquinavir ... The investigators measured blood levels of saquinavir in eight of the patients ... Aidsmap

CROI: Saquinavir-based combination prevents mother-to-child HIV …  -  Feb 22, 2006
Short-term anti-HIV drug combinations including ritonavir (Norvir)-boosted saquinavir (Invirase) are more effective at reducing viral loads in the third ... Aidsmap

Boosted Saquinavir Appears Safe, Effective in HIV-Infected Pregnant …  -  Oct 29, 2008
By Ed Susman. WASHINGTON, DC -- October 29, 2008 -- Pregnant women infected with HIV do not lose protection of the protease inhibitor saquinavir when that ... DG News

Boosted saquinavir has similar potency, better lipid profile than...  -  Nov 14, 2006
Early results from a head-to-head comparison of boosted saquinavir with boosted lopinavir (Kaletra) suggest that the drugs achieve similar virological ... Aidsmap

Rifampin Plus Ritonavir-Boosted Saquinavir Therapy Linked to High...  -  Feb 10, 2005
Feb. 10, 2005 — The US Food and Drug Administration (FDA) and Roche Laboratories, Inc., have warned healthcare professionals via letter that use of rifampin ... Medscape

Philanthropic Roche shares manufacturing technology with Africa  -  Jun 4, 2007
The companies will be able to produce saquinavir for supply throughout ... Roche introduced Invirase (saquinavir) in 1995 and was the world's first HIV ... In-PharmaTechnologist.com

Drug-Induced Hepatitis with Saquinavir/Ritonavir + Rifampin  -  Apr 6, 2005
On February 3, Roche Products, Ltd. sent a letter to investigators involved in saquinavir studies to alert them that saquinavir/ritonavir should not be ... Medscape

Interim Analysis of New Study Suggests Boosted INVIRASE(R) May …  -  Nov 13, 2006
Inhibition of CYP3A4 by saquinavir could result in elevated plasma concentrations ... Garlic capsules should not be used while taking saquinavir as the sole ... Free with registration - PR Newswire - AccessMyLibrary.com

… -Positive Patients Confirms Boosted Saquinavir Has Comparable...  -  Jul 27, 2007
...[Presentation title: Saquinavir/Ritonavir BID Vs Lopinavir/Ritonavir BID Plus Emtricitabine/Tenofovir QD as Initial Therapy in HIV-1-Infected Patients: The ... DG News

… enters tech transfer deals with four African/Asian firms for saquin...  -  Jan 21, 2008
The companies will be able to produce saquinavir for supply throughout countries in sub-Saharan Africa, and to those defined as least developed by the ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Swiss pharmaceutical firm Roche to help three African companies …  -  Sep 22, 2006
Saquinavir is a so-called "second-line" (support) treatment which is ... "Saquinavir is a product that many international experts consider useful, ... radio rottu oberwallis

Double-Boosted Saquinavir/Lopinavir Combination Safe and Effective...  -  Feb 7, 2008
By Maria Bishop. BOSTON, MA -- February 7, 2008 -- Double-boosted saquinavir/lopinavir (SQV/LPV/r) demonstrated a significant increase in CD4 cell counts ... DG News

New Study Results Find That Patients Treated With Boosted INVIRASE, A...  -  Jul 25, 2005
INVIRASE may be used only if it is combined with ritonavir, which significantly inhibits saquinavir's metabolism to provide plasma saquinavir levels at ... $4.95 - PR Newswire - ECNext

New AIDS Technology Transfers free of charge reinforce Roche's …  -  May 31, 2007
The companies will be able to produce saquinavir for supply throughout Ethiopia and Zimbabwe in addition to any country within sub-Saharan Africa or defined ... webwire.com

Fortovase (saquinavir): a complete guide from AIDSmeds.com  -  Nov 13, 2006
Fortovase is an anti-HIV medication. It is in a category of HIV medications called protease inhibitors (PIs). Fortovase prevents T-cells that have been ... AIDSmeds.com HIV/AIDS Treatment News

HIV/AIDS-Associated Infection; Saquinavir & miconazole synergistic …  -  Jan 25, 2005
2005 JAN 25 - (NewsRx.com & NewsRx.net) -- Saquinavir and miconazole are synergistic against Candida albicans/C. neoformans. ... Pay-Per-View - Virus Weekly - Factiva, from Dow Jones

Double Boosted Saquinavir/Lopinavir Shows Promise for Nucleoside …  -  Aug 17, 2006
By Danny Kucharsky. TORONTO, CANADA -- August 17, 2006 -- Double-boosted saquinavir (SQV)/lopinavir/ritonavir (LPV/r) appears to result in significant CD4 ... DG News

HIV/AIDS-Associated Infection; Saquinavir & miconazole synergistic …  -  Jan 24, 2005
2005 JAN 24 - (NewsRx.com & NewsRx.net) -- Saquinavir and miconazole are synergistic against Candida albicans/C. neoformans. ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones

Virtual Human In HIV Drug Simulation  -  Jan 29, 2008
These protease mutations are associated with the disease's resistance to saquinavir, an HIV-inhibitor drug. The study, by Professor Peter Coveney and ... RedOrbit

… and Safety With Once-Daily Ritonavir-Boosted Saquinavir Plus 2...  -  Aug 18, 2006
TORONTO, CANADA -- August 18, 2006 -- Once-daily saquinavir/ritonavir- (SQV/r) based highly active antiretroviral therapy (HAART) shows excellent long-term ... DG News

HIV/AIDS Therapy; New research in the area of HIV/AIDS therapy...  -  Mar 9, 2005
..."Lopinavir concentrations were similar in patients with and without saquinavir. The median pharmacokinetic parameters for saquinavir were as follows: ... Pay-Per-View - Immunotherapy Weekly - Factiva, from Dow Jones

… ; Self-reported HAART adherence and saquinavir AUC predict virologic...  -  Jan 2, 2006
..."Counts of remaining saquinavir capsules were determined between weeks 0 and 4; ... Only self-reported adherence and saquinavir AUC were significantly ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones

HIV/AIDS Therapy; New research in the area of HIV/AIDS therapy...  -  Mar 12, 2005
..."Lopinavir concentrations were similar in patients with and without saquinavir. The median pharmacokinetic parameters for saquinavir were as follows: ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Basel, Switzerland (May 29)--Roche formed an agreement with two …  -  Jul 1, 2007
The companies will be able to produce Saquinavir for Ethiopia, Zimbabwe, and any other country within sub-Saharan Africa or defined as "least developed" by ... $9.94 - Pharmaceutical Technology - Alacra Store

HIV/AIDS Therapy; New research in the area of HIV/AIDS therapy...  -  Mar 7, 2005
..."Lopinavir concentrations were similar in patients with and without saquinavir. The median pharmacokinetic parameters for saquinavir were as follows: ... Pay-Per-View - AIDS Weekly - Factiva, from Dow Jones

CYP3A5 Genotype Has No Impact on Plasma Trough Concentrations of …  -  Sep 6, 2007
When included in HAART regimens, saquinavir is administered in repeated doses over long periods of time, and in combination with a ritonavir booster. ... Nature.com

Kaletra, saquinavir have anti-malarial effects in test tube  -  Oct 5, 2006
Protease inhibitors can give HIV-infected people at least partial protection against malaria, Australian researchers told delegates at last week's ... Aidsmap

… potentiates antitumor effects of saquinavir against lymphoma cells  -  Feb 28, 2005
..."We report here that lovastatin and saquinavir exert cytostatic/cytotoxic effects against Daudi and Raji human lymphoma cells. Importantly," said T. Issat ... Pay-Per-View - Cardiovascular Week - Factiva, from Dow Jones

New Data Suggest Boosted Invirase(R) has Similar Efficacy to Boosted ...  -  Jul 20, 2007
Inhibition of CYP3A4 by saquinavir could result in elevated plasma concentrations ... Garlic capsules should not be used while taking saquinavir as the sole ... Free with registration - PR Newswire - AccessMyLibrary.com

Schor v. Abbott Laboratories, 457 F.3d 608 (7th Cir. 07/26/2006)  -  Jul 26, 2006
For example, a standard dose of FORTOVASE® (saquinavir) is 1200 mg three times ... In addition to lopinavir and saquinavir, which we have already mentioned, ... $2.95 - U.S. Court of Appeals, Seventh Circuit - VersusLaw

… /AIDS Therapy; Multidrug resistance-associated proteins limit saquin...  -  Apr 26, 2005
Keywords: Piscataway, New Jersey, United States, Saquinavir, AIDS & HIV Therapy, Anti-Infectives, Biotechnology, Drug Delivery, Neuroscience, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

… ; Poly(ethylene glycol)-based saquinavir prodrug conjugates...  -  Feb 15, 2005
According to recent research published in the journal Bioconjugate Chemistry, "Various poly(ethylene glycol)(PEG)-based prodrug conjugates of the HIV-1 ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

… ; Poly(ethylene glycol)-based saquinavir prodrug conjugates...  -  Feb 18, 2005
According to recent research published in the journal Bioconjugate Chemistry, "Various poly(ethylene glycol)(PEG)-based prodrug conjugates of the HIV-1 ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

… ; Poly(ethylene glycol)-based saquinavir prodrug conjugates...  -  Feb 14, 2005
According to recent research published in the journal Bioconjugate Chemistry, "Various poly(ethylene glycol)(PEG)-based prodrug conjugates of the HIV-1 ... Pay-Per-View - Hematology Week - Factiva, from Dow Jones

Europe approves new Invirase 500 mg tablet for the treatment of HIV  -  May 27, 2005
Invirase (saquinavir) was the first protease inhibitor (PI) and was introduced ... Invirase/r (saquinavir 1000/ritonavir 100mg twice daily) has shown high ... Medical News Today - Medical News Today (press release)

… /AIDS Therapy; Multidrug resistance-associated proteins limit saquin...  -  Apr 30, 2005
Keywords: Piscataway, New Jersey, United States, Saquinavir, AIDS & HIV Therapy, Anti-Infectives, Biotechnology, Drug Delivery, Neuroscience, ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

… potentiates antitumor effects of saquinavir against lymphoma cells  -  Mar 3, 2005
..."We report here that lovastatin and saquinavir exert cytostatic/cytotoxic effects against Daudi and Raji human lymphoma cells. Importantly," said T. Issat ... Pay-Per-View - Blood Weekly - Factiva, from Dow Jones

肯尼亚获准自产一ç§?抗艾滋病病毒è?¯å“?  -  Jan 23, 2008
...民�报》22日报�,肯尼亚雷加尔��公�已获得瑞士罗�控股公�的�费技术转让, 将生产抗艾滋病病毒的蛋白酶抑制剂——沙奎那韦(S�quin�vir)。 ... 新�网甘肃频�

Fortovase (saquinavir, free base) withdrawal of the marketing …  -  Aug 7, 2006
On 20 Aug 1998 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Fortovase, ... Pay-Per-View - EMEA (European Medicines Agency) - Factiva, from Dow Jones

Final Gemini Study Results Confirm Boosted Invirase Was as Effective...  -  Oct 25, 2007
Inhibition of CYP3A4 by saquinavir could result in elevated plasma concentrations ... Garlic capsules should not be used while taking saquinavir as the sole ... Free with registration - Business Wire - AccessMyLibrary.com

HIV/AIDS Therapy; Invirase receives FDA marketing approval  -  Jan 17, 2005
Invirase (saquinavir mesylate) is an HIV protease inhibitor approved for use in ... "In the Staccato trial patients treated with saquinavir/ritonavir showed ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones

… ; Ritonavir has double-boosting function for both lopinavir and...  -  Feb 7, 2005
..."Lopinavir concentrations were similar in patients with and without saquinavir. The median pharmacokinetic parameters for saquinavir were as follows: ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

HIV/AIDS Therapy; Study shows effectiveness of protease inhibitor in ...  -  Aug 24, 2005
2005 AUG 24 - (NewsRx.com) -- Patients starting HIV treatment with Roche's protease inhibitor INVIRASE (saquinavir mesylate) boosted with a small dose of ... Pay-Per-View - Vaccine Weekly - Factiva, from Dow Jones

Functional role of P-glycoprotein in the human blood-placental barrier  -  Apr 27, 2005
Saquinavir was used as a probe drug for P-glycoprotein-dependent active ... Preperfusion with PSC833 increased the placental transfer of saquinavir by ... Nature.com

… ; Ritonavir has double-boosting function for both lopinavir and...  -  Feb 10, 2005
..."Lopinavir concentrations were similar in patients with and without saquinavir. The median pharmacokinetic parameters for saquinavir were as follows: ... Pay-Per-View - Blood Weekly - Factiva, from Dow Jones

… ; Ritonavir has double-boosting function for both lopinavir and...  -  Feb 12, 2005
..."Lopinavir concentrations were similar in patients with and without saquinavir. The median pharmacokinetic parameters for saquinavir were as follows: ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Burkina Faso: Le Saquinavir, un générique anti-VIH  -  Jul 17, 2007
Le groupe Roche a signé, avec l'Ethiopie et le Zimbabwe, deux accords prévoyant le transfert gratuit du savoir-faire technique permettant de produire ... AllAfrica.com - allafrica.com

肯尼亞ç?²æº–自產一種抗艾滋病病毒藥å“?  -  Jan 23, 2008
...民�報》22日報�,肯尼亞雷加爾藥�公�已�得瑞士羅�控股公�的�費技術轉讓, 將生產抗艾滋病病毒的蛋白酶抑制劑——沙奎那韋(S�quin�vir)。 ... 新�網

… on Availability of INVIRASE(R), Now Preferred Formulation of Saquin...  -  Feb 6, 2006
Saquinavir hard-gel (Invirase) is only recommended when combined ... ... INVIRASE(R) (saquinavir ... capsules and FORTOVASE(R) (saquinavir ... antiviral ... Pay-Per-View - PR Newswire - HighBeam Research

Roche transfère le Saquinavir  -  Jan 13, 2006
Le groupe pharmaceutique Roche va transférer à des fabricants d'Afrique sub-saharienne le savoir-faire technique nécessaire à la production de génériques du ... Libération

HN77 Saquinavir + Ritonavir  -  Jul 10, 2007
Saquinavir en ritonavir worden vaak in combinatie gebruikt. Vroeger werd dat meestal gedaan in de verhouding 400mg/400mg tweemaal daags. ... Hiv Vereniging Nederland

The Times - <b>R - Z</b>  -  Oct 22, 2008
Invirase, the first formulation of Saquinavir, had low anti-HIV activity in the ... Combining Saquinavir with Ritonavir raises its blood levels by ten-fold, ... The Times

Press Release: Roche to Voluntarily Withdraw Anti-HIV Medication …  -  May 18, 2005
INVIRASE(R) (saquinavir ... capsules and Fortovase(R) (saquinavir ... antiviral regimen, Fortovase is the recommended formulation. ... Pay-Per-View - PR Newswire - HighBeam Research

Invirase (saquinavir, SQV)  -  Mar 1, 2008
Invirase es un medicamento anti-VIH que pertenece a la categoría de los inhibidores de la proteasa (IP). Invirase evita que las células que están infectadas ... AIDSmeds.com HIV/AIDS Treatment News

Drogas antisida serían eficaces contra el cáncer  -  Sep 7, 2007
Los dos antivirales más potentes fueron el nelfinavir y el saquinavir: no sólo lograron frenar el crecimiento antitumoral, sino que también aceleraron un ... Clarín.com

Article: Roche snaps up InterMune treatment - Oakland Tribune | …  -  Oct 17, 2006
Article: ROCHE HIV PROTEASE INHIBITOR SAQUINAVIR ... PR Newswire; October 23, 2000 ; 700+ words ... ... Ltd Glasgow, UK - Roche has announced the results ... Pay-Per-View - Oakland Tribune - HighBeam Research

SIDA: Roche partage son savoir-faire avec l'Afrique  -  Sep 22, 2006
«Le Saquinavir est un produit considéré comme utile par beaucoup d'experts internationaux. Et Roche va au-delà de la simple cession volontaire de licences ... TSR.ch

Roche transfiere su saquinavir  -  Jan 14, 2008
La multinacional suiza Roche ha llegado a un acuerdo con cuatro compañías fabricantes de medicamentos en �frica y Asia -Regal Pharmaceuticals, en Kenia; ... Diario Médico - Diario Médico (Suscripción)

Versterkte saquinavir versus Kaletra  -  Jul 10, 2007
In de Gemini-studie (gesponsord door Roche) is met ritonavir versterkte saquinavir + Truvada vergeleken met Kaletra + Truvada bij 337 hiv-positieven die nog ... Hiv Vereniging Nederland

Lopinavir/ritonavir not linked to hepatotoxicity regardless of HCV...  -  Jan 25, 2005
HCV seropositivity rates ranged from 39% in the saquinavir/ritonavir group to 49% in the nelfinavir group, while the overall HBV seroprevalence rate was ... Aidsmap

Versterkte saquinavir versus Kaletra  -  Jan 10, 2007
In de Gemini-studie (gesponsord door Roche) is met ritonavir versterkte saquinavir (Invirase) + Truvada vergeleken met Kaletra + Truvada bij 337 ... Hiv Vereniging Nederland

L'essere umano virtuale fornisce informazioni sull'efficacia di un...  -  Jan 31, 2008
Il saquinavir è solo uno dei nove farmaci studiati per bloccare la proteasi HIV-1. Attualmente, i medici non hanno modo di adeguare il farmaco alle ... Le Scienze Web News

Avance en el apego del paciente al tratamiento antirretroviral  -  Jun 7, 2007
Es el caso del inhibidor de proteasa llamado saquinavir, que tenía una ... Saquinavir fue el primer antirretroviral inhibidor de la proteasa que se usó en ... La Jornada - La Jornada (México)

Saquinavir 500 mg: Neue Formulierung – weniger Tabletten  -  Jun 15, 2005
Der zur Behandlung von HIV-Infektionen eingesetzte Protease-Inhibitor Saquinavir ist ab sofort in der neuen Formulierung 500 mg Filmtabletten in Deutschland ... journalmed.de

HN77 Kaletra plus saquinavir  -  Jul 10, 2007
Bij sommige hiv-positieven die al vele jaren hiv-remmers hebben gebruikt, is het hiv resistent tegen alle nucleoside analogen. Die middelen zullen bij hen ... Hiv Vereniging Nederland

Eenmaal daags saquinavir  -  Jul 10, 2007
In Thailand is eenmaal daags saquinavir (Invirase 1600 mg) opgevoerd met een lage dosis (100 mg) ritonavir in de Staccato-trial onderzocht bij 167 ... Hiv Vereniging Nederland

… HIV-Behandlungsrichtlinien empfehlen geboostetes Saquinavir als …  -  Nov 29, 2005
Eine zweimal täglich verabreichte Dosis Saquinavir/Ritonavir - 1000/100 mg – in Verbindung mit anderen antiretroviralen Medikamenten bedeutet für Ärzte und ... journalmed.de

HN80 Efavirenz versus saquinavir  -  Jul 10, 2007
In meerdere trials lijkt efavirenz effectiever te zijn dan proteaseremmers. Maar of efavirenz effectiever is dan een proteaseremmer plus wat ritonavir is ... Hiv Vereniging Nederland

Roche stopt met ddC en Fortovase; introduceert Invirase 500 mg  -  Jul 10, 2007
Fortovase is saquinavir in een zachte capsule. Wanneer de bloedspiegel van saquinavir niet wordt opgevoerd door ritonavir dan wordt het middel als Fortovase ... Hiv Vereniging Nederland

Pharmacology; Effects of grapefruit and orange juice on MRP2-mediated...  -  Feb 21, 2005
..."Studies of transport and uptake of [3H]VBL and [14C]saquinavir with MDR1 and MRP2 transfectants showed that VBL and saquinavir are transported by both P-gp ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Roche unterstützt arme Länder bei Herstellung von Aids-Mitteln  -  Jan 12, 2006
...den 64 ärmsten Ländern Afrikas und Asiens das erforderliche Wissen zur Herstellung des Aids-Medikamentes Saquinavir, wie Roche am Donnerstag mitteilte. ... FinanzNachrichten.de

Pharmacology; Effects of grapefruit and orange juice on MRP2-mediated...  -  Feb 26, 2005
..."Studies of transport and uptake of [3H]VBL and [14C]saquinavir with MDR1 and MRP2 transfectants showed that VBL and saquinavir are transported by both P-gp ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

THE RIGHT TO A TRIAL.  -  Dec 18, 2006
Hoffman-LaRoche, the company that made saquinavir, invited several ... Saquinavir proved to be strikingly effective against HIV Within a few months, ... Free with registration - New Yorker - AccessMyLibrary.com

Press Release: Interim Analysis of New Study Suggests Boosted …  -  Nov 13, 2006
Roche's protease inhibitor Invirase (saquinavir mesylate ... fewer patients treated with Invirase developed elevated triglyceride ... lead investigator on ... Pay-Per-View - PR Newswire - HighBeam Research

HN70 Mozenavir (DMP450)  -  Jul 10, 2007
De interactie tussen mozenavir enerzijds en indinavir of saquinavir anderzijds is bij ... Indinavir en saquinavir hadden geen effect op de bloedspiegel van ... Hiv Vereniging Nederland

Roche HIV drug move greeted with scepticism  -  Dec 12, 2005
Reinhard also claimed that saquinavir was never prescribed on its own, but usually in ... He questioned the merits of manufacturing saquinavir alone. ... radio rottu oberwallis

Door Hiv Vereniging Nederland  -  Jul 10, 2007
In hetzelfde nummer stond dat in een onderzoek waarin saquinavir versterkt met ritonavir werd vergeleken met Kaletra de behandeling na 24 weken succesvol ... Hiv Vereniging Nederland

Firmen in Afrika dürfen Aids-Medikamente von Roche herstellen  -  Sep 22, 2006
Es geht um Saquinavir. Die Vereinbarungen sind die ersten einer Reihe von geplanten Maßnahmen im Zuge des Technologietransfers, den Roche im Januar ... dieneueepoche.com

Un farmaco anti-Aids è un'ottima arma contro il cancro  -  Sep 4, 2007
Gli altri due farmaci con effetti inibenti la crescita delle cellule tumorali sono Ritonavir e Saquinavir®. Gli inibitori delle proteasi sono stati ... DIARIODELWEB.it

Gilead rains manufacturing deals on India's generic firms  -  Sep 26, 2006
Manufacturers in sub-Saharan Africa and least developed countries wishing to produce generic saquinavir for use in these regions will not be required to ... In-PharmaTechnologist.com

HIV/AIDS Therapy; Protease inhibitors impair glucose-stimulated...  -  Mar 21, 2005
..."Incubation for 48 hours with ritonavir, nelfinavir and saquinavir resulted in impaired glucose-induced insulin secretion at 2.5, 5 and 5 mcM respectively, ... Pay-Per-View - Obesity & Diabetes Week - Factiva, from Dow Jones

Article: Garlic Doesn't Wow 'Em - The Washington Post | HighBeam …  -  Mar 6, 2007
...take garlic supplements or medications, the participants ... pathway into the body. Exactly how garlic supplements disrupt the uptake of saquinavir ... ... Pay-Per-View - Washington Post - HighBeam Research

Ruhr University of Bochum; Protease inhibitors impair glucose...  -  Mar 23, 2005
..."Incubation for 48 hours with ritonavir, nelfinavir and saquinavir resulted in impaired glucose-induced insulin secretion at 2.5, 5 and 5 mcM respectively, ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

HIV/AIDS Therapy; Protease inhibitors impair glucose-stimulated...  -  Mar 27, 2005
..."Incubation for 48 hours with ritonavir, nelfinavir and saquinavir resulted in impaired glucose-induced insulin secretion at 2.5, 5 and 5 mcM respectively, ... Pay-Per-View - Medical Devices & Surgical Technology... - Factiva, from Dow Jones

Brand Names/Synonyms:
Saquinavir is also known by the following brand names and/or synonymsFortovase; Invirase; ROC; SAQUINAVIR; SQV; Saquinavir; Saquinavir Mesylate; Saquinavir [Usan]

Drug Category:
Saquinavir is categorized under the following by the FDA: Anti-HIV Agents; Anti-HIV Agents; ATC:J05AE01

Dosage Forms:
INVIRASE (saquinavir mesylate) capsules and FORTOVASE (saquinavir) soft gelatin capsules

Absorption:
Absolute bioavailability of saquinavir administered as INVIRASE averaged 4%

Interactions:
[an error occurred while processing this directive]

Chemical IUPAC Name:
N-[1-benzyl-2-hydroxy-3-[3-(tert-butylcarbamoyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinolin-2-yl]-propyl]-2-quinolin-2-ylcarbonylamino-butanediamide





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy